Nucor Financials
This page shows Nucor (NUE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Nucor's revenue declined 11.5% year-over-year, from $34.7B to $30.7B. This contraction results in a growth score of 0/100.
Nucor carries a low D/E ratio of 0.28, meaning only $0.28 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 2.51, Nucor holds $2.51 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 80/100.
While Nucor generated $4.0B in operating cash flow, capex of $3.2B consumed most of it, leaving $806.0M in free cash flow. This results in a low score of 13/100, reflecting heavy capital investment rather than weak cash generation.
Nucor's ROE of 10.0% shows moderate profitability relative to equity, earning a score of 40/100. This is down from 21.6% the prior year.
Nucor passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Nucor generates $1.96 in operating cash flow ($4.0B OCF vs $2.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Nucor generated $30.7B in revenue in fiscal year 2024. This represents a decrease of 11.5% from the prior year.
Nucor generated $806.0M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 83.5% from the prior year.
Nucor reported $2.0B in net income in fiscal year 2024. This represents a decrease of 55.2% from the prior year.
Nucor held $3.6B in cash against $5.7B in long-term debt as of fiscal year 2024.
Nucor paid $2.17 per share in dividends in fiscal year 2024. This represents an increase of 4.8% from the prior year.
Nucor's gross margin was 13.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 9.2 percentage points from the prior year.
Nucor's net profit margin was 6.6% in fiscal year 2024, showing the share of revenue converted to profit. This is down 6.4 percentage points from the prior year.
Nucor's ROE was 10.0% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 11.6 percentage points from the prior year.
Nucor spent $2.2B on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 42.7% from the prior year.
Nucor invested $3.2B in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 43.3% from the prior year.
NUE Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.5B+0.8% | $8.5B+8.0% | $7.8B+10.7% | $7.1B-4.9% | $7.4B-7.8% | $8.1B-0.7% | $8.1B+5.6% | $7.7B |
| Cost of Revenue | $7.3B+1.4% | $7.2B+0.1% | $7.2B+12.0% | $6.4B-3.5% | $6.7B-2.9% | $6.9B+4.1% | $6.6B+4.8% | $6.3B |
| Gross Profit | $1.2B-2.9% | $1.2B+102.1% | $605.0M-3.5% | $627.0M-17.3% | $758.0M-36.5% | $1.2B-21.6% | $1.5B+9.3% | $1.4B |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $300.0M-1.3% | $304.0M+8.2% | $281.0M+17.1% | $240.0M-1.6% | $244.0M-17.0% | $294.0M-14.8% | $345.0M-3.1% | $355.9M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $38.0M-22.4% | $49.0M-3.9% | $51.0M-3.8% | $53.0M-18.5% | $65.0M-3.0% | $67.0M+55.8% | $43.0M-27.5% | $59.3M |
| Income Tax | $200.0M+3.6% | $193.0M+227.1% | $59.0M+31.1% | $45.0M-47.7% | $86.0M-53.8% | $186.0M-30.1% | $266.0M+29.6% | $205.3M |
| Net Income | $607.0M+0.7% | $603.0M+286.5% | $156.0M-45.6% | $287.0M+14.8% | $250.0M-61.2% | $645.0M-23.7% | $845.0M+7.6% | $785.0M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NUE Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.8B+1.6% | $34.2B-1.4% | $34.7B+2.2% | $33.9B-1.2% | $34.3B+0.5% | $34.2B+0.7% | $33.9B-4.0% | $35.3B |
| Current Assets | $11.8B+0.8% | $11.7B-8.2% | $12.8B+2.3% | $12.5B-7.7% | $13.5B-5.2% | $14.3B-2.6% | $14.6B-10.6% | $16.4B |
| Cash & Equivalents | $2.2B+14.1% | $1.9B-38.3% | $3.2B-11.3% | $3.6B-16.5% | $4.3B-8.1% | $4.6B+1.8% | $4.6B-28.6% | $6.4B |
| Inventory | $5.4B-1.3% | $5.5B+3.9% | $5.3B+2.9% | $5.1B-0.4% | $5.1B-2.5% | $5.3B-6.0% | $5.6B+0.2% | $5.6B |
| Accounts Receivable | $3.3B-3.0% | $3.4B+14.3% | $3.0B+10.8% | $2.7B-9.3% | $2.9B-5.3% | $3.1B-1.4% | $3.2B+6.9% | $3.0B |
| Goodwill | $4.3B-0.1% | $4.3B+0.3% | $4.3B0.0% | $4.3B+0.3% | $4.3B+6.8% | $4.0B+1.1% | $4.0B-0.3% | $4.0B |
| Total Liabilities | $12.8B+0.9% | $12.7B-6.3% | $13.6B+8.5% | $12.5B-2.1% | $12.8B+3.0% | $12.4B+1.7% | $12.2B-7.6% | $13.2B |
| Current Liabilities | $4.3B+2.7% | $4.1B-18.0% | $5.1B+1.6% | $5.0B-4.6% | $5.2B+7.2% | $4.9B+33.4% | $3.6B-20.7% | $4.6B |
| Long-Term Debt | $6.7B-0.1% | $6.7B0.0% | $6.7B+17.7% | $5.7B0.0% | $5.7B+0.6% | $5.6B-15.0% | $6.6B0.0% | $6.6B |
| Total Equity | $20.8B+1.9% | $20.4B+1.6% | $20.1B-1.1% | $20.3B-0.9% | $20.5B-1.2% | $20.7B+0.1% | $20.7B-1.2% | $20.9B |
| Retained Earnings | $31.3B+1.6% | $30.8B+1.6% | $30.3B+0.1% | $30.3B+0.5% | $30.1B+0.4% | $30.0B+1.7% | $29.5B+2.5% | $28.8B |
NUE Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B+82.9% | $732.0M+101.1% | $364.0M-50.3% | $733.0M-43.7% | $1.3B-12.4% | $1.5B+222.8% | $460.0M-69.7% | $1.5B |
| Capital Expenditures | $807.0M-15.4% | $954.0M+11.1% | $859.0M-2.3% | $879.0M+6.8% | $823.0M+2.7% | $801.0M+19.6% | $670.0M-6.7% | $717.8M |
| Free Cash Flow | $532.0M+339.6% | -$222.0M+55.2% | -$495.0M-239.0% | -$146.0M-130.5% | $478.0M-30.1% | $684.0M+425.7% | -$210.0M-126.2% | $802.6M |
| Investing Cash Flow | -$786.0M-44.8% | -$543.0M+54.0% | -$1.2B-22.4% | -$964.0M+17.5% | -$1.2B-64.4% | -$711.0M+20.1% | -$890.0M-35.8% | -$655.5M |
| Financing Cash Flow | -$273.0M+80.6% | -$1.4B-440.6% | $414.0M+189.8% | -$461.0M+9.6% | -$510.0M+26.2% | -$691.0M+50.5% | -$1.4B-300.4% | -$348.7M |
| Dividends Paid | $127.0M-1.6% | $129.0M0.0% | $129.0M+0.8% | $128.0M-1.5% | $130.0M0.0% | $130.0M-3.0% | $134.0M+5.5% | $127.0M |
| Share Buybacks | $100.0M-50.0% | $200.0M-33.3% | $300.0M-5.1% | $316.0M-21.0% | $400.0M-20.0% | $500.0M-50.0% | $1.0B+464.8% | $177.2M |
NUE Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.9%-0.5pp | 14.5%+6.7pp | 7.7%-1.1pp | 8.9%-1.3pp | 10.2%-4.6pp | 14.8%-3.9pp | 18.7%+0.6pp | 18.1% |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 7.1%-0.0pp | 7.1%+5.1pp | 2.0%-2.1pp | 4.1%+0.7pp | 3.4%-4.6pp | 8.0%-2.4pp | 10.4%+0.2pp | 10.2% |
| Return on Equity | 2.9%-0.0pp | 3.0%+2.2pp | 0.8%-0.6pp | 1.4%+0.2pp | 1.2%-1.9pp | 3.1%-1.0pp | 4.1%+0.3pp | 3.8% |
| Return on Assets | 1.8%0.0pp | 1.8%+1.3pp | 0.4%-0.4pp | 0.9%+0.1pp | 0.7%-1.2pp | 1.9%-0.6pp | 2.5%+0.3pp | 2.2% |
| Current Ratio | 2.77-0.1 | 2.83+0.3 | 2.52+0.0 | 2.51-0.1 | 2.59-0.3 | 2.93-1.1 | 4.02+0.4 | 3.57 |
| Debt-to-Equity | 0.320.0 | 0.330.0 | 0.33+0.1 | 0.280.0 | 0.280.0 | 0.27-0.0 | 0.320.0 | 0.32 |
| FCF Margin | 6.2%+8.9pp | -2.6%+3.7pp | -6.3%-4.3pp | -2.1%-8.5pp | 6.4%-2.1pp | 8.5%+11.1pp | -2.6%-13.0pp | 10.4% |
Similar Companies
Frequently Asked Questions
What is Nucor's annual revenue?
Nucor (NUE) reported $30.7B in total revenue for fiscal year 2024. This represents a -11.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nucor's revenue growing?
Nucor (NUE) revenue declined by 11.5% year-over-year, from $34.7B to $30.7B in fiscal year 2024.
Is Nucor profitable?
Yes, Nucor (NUE) reported a net income of $2.0B in fiscal year 2024, with a net profit margin of 6.6%.
How much debt does Nucor have?
As of fiscal year 2024, Nucor (NUE) had $3.6B in cash and equivalents against $5.7B in long-term debt.
What is Nucor's gross margin?
Nucor (NUE) had a gross margin of 13.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Nucor's net profit margin?
Nucor (NUE) had a net profit margin of 6.6% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Nucor pay dividends?
Yes, Nucor (NUE) paid $2.17 per share in dividends during fiscal year 2024.
What is Nucor's return on equity (ROE)?
Nucor (NUE) has a return on equity of 10.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Nucor's free cash flow?
Nucor (NUE) generated $806.0M in free cash flow during fiscal year 2024. This represents a -83.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Nucor's operating cash flow?
Nucor (NUE) generated $4.0B in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Nucor's total assets?
Nucor (NUE) had $33.9B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Nucor's capital expenditures?
Nucor (NUE) invested $3.2B in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
Does Nucor buy back shares?
Yes, Nucor (NUE) spent $2.2B on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
What is Nucor's current ratio?
Nucor (NUE) had a current ratio of 2.51 as of fiscal year 2024, which is generally considered healthy.
What is Nucor's debt-to-equity ratio?
Nucor (NUE) had a debt-to-equity ratio of 0.28 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nucor's return on assets (ROA)?
Nucor (NUE) had a return on assets of 6.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Nucor's Piotroski F-Score?
Nucor (NUE) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nucor's earnings high quality?
Nucor (NUE) has an earnings quality ratio of 1.96x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Nucor?
Nucor (NUE) scores 47 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.